Drug ID: | NPD7113 |
Drug Name: | |
Molecular Formula: | C28H38N4O6 |
Canonical SMILES: | O=C([C@@H]1CO1)CCCCC[C@@H]1N=C(O)[C@H]2CCCN2C(=O)[C@@H](N=C(C(N=C1O)(C)C)O)Cc1ccccc1 |
Standard InCHI: | InChI=1S/C28H38N4O6/c1-28(2)27(37)30-20(16-18-10-5-3-6-11-18)26(36)32-15-9-13-21(32)25(35)29-19(24(34)31-28)12-7-4-8-14-22(33)23-17-38-23/h3,5-6,10-11,19-21,23H,4,7-9,12-17H2,1-2H3,(H,29,35)(H,30,37)(H,31,34)/t19-,20-,21+,23-/m0/s1 |
Standard InCHIKey: | SGYJGGKDGBXCNY-QXUYBEEESA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7